SCHEMBL6403658

SCHEMBL6403658

Cc1cc(C(c2ccccc2)c2cc(C)c(N)c(C)c2C)c(C)c(C)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ DPP4 P27487 2/20 0.32
▸ F2 P00734 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MGAM O43451 1/20 0.32
▸ SI P14410 1/20 0.32
▸ MGAM2 Q2M2H8 1/20 0.32
▸ ACP3 P15309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22044348 0.78 SLC6A2 (0.41) ALDH1A1CYP1A1CYP1A2CYP2C9CYP2C19
SCHEMBL30485783 0.78 GAA (0.40) GAATSHRTDP1ACP3KMT2A
SCHEMBL1176905 0.78 GAA (0.40) GAATSHRTDP1ACP3KMT2A
SCHEMBL3687485 0.76 ALDH1A1 (0.42) ALDH1A1POLBCYP1A1CYP1A2CYP2C9
SCHEMBL28205472 0.76 ALDH1A1 (0.42) ALDH1A1POLBCYP1A1CYP1A2CYP2C9
SCHEMBL8579882 0.76 CYP3A4 (0.38) ALDH1A1POLBCYP1A2CYP2C9CYP2C19
SCHEMBL8130850 0.76 CYP3A4 (0.43) ALDH1A1POLBCYP2C9CYP2C19GAA
SCHEMBL30075904 0.74 DPP4 (0.37) CYP1A1CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL30506418 0.74 SLC6A2 (0.41) ALDH1A1CYP1A1CYP1A2CYP2C9CYP2C19
SCHEMBL22129184 0.74 DPP4 (0.37) CYP1A1CYP1A2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6849345-B2 Organic electroluminescent devices with high luminance EASTMAN KODAK COMPANY (US) 2005-02-01 — — US disclosed
US-20030129449-A1 Organic electroluminescent devices with high luminance EASTMAN KODAK COMPANY 2003-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030129449-A1 Organic electroluminescent devices with high luminance ARL1, ALDH1A2, EML4 ALDH1A1 25/4885POLB 2342/4885CYP1A1 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback